Morgan Stanley is out with its report today on Aflac AFL, lowering its PT from $69 to $64.
In a note to clients, Morgan Stanley writes, "For longer-term investors, we
continue to see potential upside and recommend accumulating a position in the stock on any further weakness. Clearly the impact of portfolio repositioning
is going to have a larger negative impact on near-term earnings than investors expected, leading to the disappointing guidance for 2012. Accordingly, the
near-term outlook is clouded, making it difficult to determine the likely incremental buyer. Longer-term, however, we believe the core franchise, remains strong, and the growth profile beyond 2012 should accelerate. We are reducing our 2012 EPS estimate $0.25 to $6.40 and lowering our 12-month price target to by $5 to $64, which is 10x our 2012e EPS."
Shares of AFL closed Wednesday at $50.45, down 6.31% from Tuesday's close.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: Analyst ColorPrice TargetAnalyst RatingsAflacFinancialsLife & Health InsuranceMorgan Stanley
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in